Cutaquig
NDC 0069-1509, immunoglobulin G, solution, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-1509
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125668
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1509 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HUMAN IMMUNOGLOBULIN G165 mg/mL
Pharmacologic classes
Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-1509-02 | 00069150902 | 1 VIAL, GLASS in 1 CARTON (0069-1509-02) / 24 mL in 1 VIAL, GLASS (0069-1509-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0069-1509
Use it
Look up 0069-1509 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1509 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-1509. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.